dBMEDx™ , Inc. Wins the 2016 Prime Health Challenge

Littleton, CO – November 2, 2016

dBMEDx was selected as the winner of the 2016 Prime Health Challenge. The company received a $75,000 cash award and was selected by two hospital groups to host a pilot clinical study of the new BBS Revolution™ bladder scanner, which was first launched by the company in 2015.

The BBS RevolutionTM is a next generation bladder scanner that offers nurses, for the first time, a fully automated bladder volume measurement solution. It delivers unparalleled ease of use, speed and accuracy for this routinely conducted test. This device is designed to support front line nurses who are conducting routine urinary test protocols to battle one of the most common infections in the hospital today, catheter-associated urinary tract infection (CAUTI), while also reducing patient-to-patient transmission risks. The BBS RevolutionTM is FDA cleared and CE marked and is commercially available in both the US and Europe.

The Prime Health Challenge brings together health innovation companies and healthcare systems to showcase new technologies and help them gain access to curated and vetted technologies and the latest healthcare innovations. Over thirty companies originally applied to participate in the challenge to compete for cash prizes and a chance to work with selected institutions on a pilot clinical study. dBMEDx was fortunate to win the top prize and will be working with Centura Health and SCL Health on clinical studies comparing the BBS RevolutionTM to existing scanning technologies.

“We are extremely grateful to Prime Health for hosting this challenge and to the Colorado Health Foundation for sponsoring the award and we are excited to be selected as the winner.” said David Shine, CEO of dBMEDx. “We have technology that nurses love and will reduce the cost of healthcare but getting it into hospitals and building awareness has been a huge challenge for us as a small, Colorado-based high tech manufacturer. The Prime Health event and the introductions and awareness it builds are very important for our company and will directly benefit the host institutions as well.”

About dBMEDx, Inc.
dBMEDx is a privately held, growth-stage medical device company focused on waging war on healthcare acquired infections. The company has developed novel, automated scanning technology with a wide range of medical applications. The first commercial product with this technology is the BBS RevolutionTM bladder scanner, the only fully automatic bladder scanner, which is currently being sold in the US and Europe. This next generation bladder scanner was designed specifically for nurses and delivers the quadruple aim of healthcare – better outcomes, lower costs, happier patients and happier providers. For additional information, please visit http://www.dBMEDx.com.


dBMEDx Contact:
David Shine – CEO

Download PDF